Saturday, September 26, 2026
6:00 AM - 7:00 AM

Registration
7:00 AM - 7:45 AM

Industry Sponsored Breakfast Symposium
7:45 AM - 7:55 AM

Break
7:55 AM - 8:00 AM

Welcome
8:00 AM - 9:00 AM

Abstract Session I
8:00 AM - 8:12 AM
Identifying Barriers to Endometrial Cancer Diagnosis Among Emergency Department Patients with Abnormal Uterine Bleeding (#001)
Speaker: Jenna Powers (McGaw Medical Center of Northwestern University)
8:12 AM - 8:24 AM
The Obesity Dividend: A Markov Cost-Effectiveness Analysis of GLP-1–Assisted Weight Loss for Conservative Management of Endometrial Intraepithelial Neoplasia (#002)
Speaker: Ashlyn Parkhurst (University of Texas Health Science Center San Antonio)
8:24 AM - 8:36 AM
Artificial Intelligence Predicts Survival and Identifies Pathologic Features Associated with Prognosis in High Grade Serous Ovarian Cancer (#003)
Speaker: Kelsey Goon (University of Chicago)
8:36 AM - 8:48 AM
A Mixed-Methodology Study on Adherence, Satisfaction, and Qualitative Perspectives After RISE, a Remote Strength Training Intervention for Endometrial Cancer Survivors (#004)
Speaker: Anusha Adkoli (Mayo Clinic)
8:48 AM - 9:00 AM
Improvement of Chemo-Response Prediction of Ovarian Cancer Treatment using Ensemble Machine Learning Analytics (#005)
Speaker: Justin Kim (University of Iowa Hospitals and Clinics)
9:00 AM - 9:45 AM

Posters/Exhibits/Networking Session I
9:45 AM - 10:45 AM

Keynote Lecture: Advancing Cancer Care for Gender Diverse Patients: Patient Perspectives and Practical Strategies to Meet the Moment
Speaker: Elizabeth Cathcart-Rake, MD
10:45 AM - 11:45 AM

Abstract Session II
10:45 AM - 10:57 AM
Cancer Specific TRA-1-60- Glyco-Epitope Enables Selective Tumor Targeting in Ovarian Cancer (#006)
Speaker: Sajmina Khatun (Wayne State University)
10:57 AM - 11:09 AM
A Real-World Comparative Study Investigating Metronomic Cyclophosphamide and Bevacizumab With or Without Pembrolizumab in Patients with Recurrent Ovarian Cancer (#007)
Speaker: Sarah Mitchem (Vandalia Health - Charleston Area Medical Center)
11:09 AM - 11:21 AM
Multi-Omic Characterization of PRMT5-High Ovarian Cancer Reveals a Targetable Proteasome Dependency (#008)
Speaker: Austin Gabel (Northwestern Memorial Hospital)
11:21 AM - 11:33 AM
Evaluating Efficacy of Ocular Toxicity Monitoring During Mirvetuximab Soravtansine Therapy (#009)
Speaker: Joshua Goyert (University of Michigan)
11:33 AM - 11:45 AM
Unimodal and Multimodal Deep Learning Analytics to Predict Chemo Response of Ovarian Cancer Treatment with CT Imaging and Clinical Data (#010)
Speaker: Katherine Sawaya (University of Iowa Health Care)
11:45 AM - 12:00 PM

Break
12:00 PM - 12:45 PM

Industry Sponsored Lunch Symposium
12:45 PM - 1:00 PM

Break
1:00 PM - 1:50 PM

Abstract Session III
1:00 PM - 1:12 PM
Ask Questions in GYnecologic Oncology (ASQ-GYO): A Randomized Controlled Trial of a Question Prompt List Communication Intervention in Outpatient Gynecologic Oncology Clinics (#011)
Speaker: Elizabeth Johns (Wayne State / Karmanos Cancer Institute)
1:12 PM - 1:24 PM
Patient Experience with Decentralized Clinical Trials (#012)
Speaker: Elizabeth Palmi (Mayo Clinic)
1:24 PM - 1:36 PM
Is Sharing Caring? A Retrospective Review Comparing Collaborative Care with Medical Oncology Versus Gynecologic Oncology Care Only for Advanced Epithelial Ovarian Cancer in Indiana (#013)
Speaker: Claire Schopper (Indiana University School of Medicine)
1:36 PM - 1:48 PM
Family Engagement and End-of-Life Care Intensity in Gynecologic Oncology: A Retrospective Cohort Study (#014)
Speaker: Margaret Schermerhorn (Rush University)
1:50 PM - 2:30 PM

Posters/Exhibits/Networking Session II
2:30 PM - 3:30 PM

Breakout Sessions
5:00 PM - 6:30 PM

Architecture Boat Tour
Sunday, September 27, 2026
7:00 AM - 7:55 AM

Sunday Breakfast Product Theater
7:55 AM - 8:00 AM

Break
8:00 AM - 9:00 AM

Keynote Lecture: Wearable Technology in Gynecologic Cancers: Improving Health and Quality of Life
Speaker: Emma Barber, MD, MS
9:00 AM - 9:45 AM

Posters/Exhibits/Networking Session III
9:45 AM - 10:45 AM

Abstract Session IV
9:45 AM - 9:57 AM
A Data-Driven Approach to Reducing Vulvectomy Wound Complications: Retrospective Review and Bundle Development (#015)
Speaker: Annie Minns (University of Michigan)
9:57 AM - 10:09 AM
Improving Post-Operative Wound Outcomes in Patients Undergoing Vulvar Surgery: Interim Results from an Ongoing Quality Improvement Initiative (#016)
Speaker: Elizabeth Farabee (University of Wisconsin)
10:09 AM - 10:21 AM
Failure to rescue after major gynecologic cancer surgery: A National Surgical Quality Improvement Program analysis (#017)
Speaker: Hannah Ahrendt (University of Wisocnsin-Madison)
10:21 AM - 10:35 AM
The Utilization and Impact of Integrative Medicine on the Management of Malignant Small Bowel Obstruction in Gynecologic Malignancies (#018)
Speaker: Sameeha Jilani (University Hospitals)
10:45 AM - 12:00 PM

State of the Society Address and Awards Brunch
Unmoderated Posters
Unmoderated Posters
Online Biographies of Gynecologic Oncologists: Analysis of Linguistic Differences Based on Gender, Graduation Year, and Region. (#019)
Speaker: Tanya Kukreja (Northwestern University Feinberg School of Medicine)
Occupational HPV Exposure and Vaccination Among Healthcare Workers: Implications for Institutional Vaccination Strategies (#020)
Speaker: Gurhan Guney (Mayo Clinic)
Human Papillomavirus Sentiment Among Women with Prior Excisional Treatment for Cervical Dysplasia (#021)
Speaker: Anna Morgan (University of Tennessee Health Science Center)
Clinicopathologic Characteristics and Molecular Outcomes of Vulvar Squamous Cell Carcinoma in a Diverse Safety-Net Population (#022)
Speaker: Ashlyn Parkhurst (University of Texas Health Science Center San Antonio)
Utility of Preoperative Nutrition Optimization in Gynecologic Oncology (#023)
Speaker: Samantha Metzger (University of Iowa Healthcare)
Bleeding Risk in Gynecologic Oncology Patients Treated with Therapeutic Low Molecular Weight Heparin Compared to Direct oral Anticoagulants (#024)
Speaker: Hannah Ahrendt (University of Wisocnsin-Madison)
Adherence to Surgico-pathologic Guidelines for Risk-Reducing Gynecologic Surgery: Comparative Evaluation of Gynecologic Surgeon Subspecialty and Clinical Outcomes (#025)
Speaker: Victoria Lynch (Carle Illinois College of Medicine)
Secondary Malignancy in Extramammary Paget’s Disease of the Vulva: A Retrospective Case Series Investigating the Yield of Costly Workup. (#026)
Speaker: Adrienne Karver (Vandalia Health)
Procedural Volume Trends in Surgical Training Among Gynecologic Oncology Fellows (#027)
Speaker: Alysia Wiener (Karmanos Cancer Institute at Detroit Medical Center, Wayne State University)
A Geographical Comparative Analysis of HPV Vaccination Rates, Cervical Cancer Rates, and Population Variables in Kentucky (#028)
Speaker: Asha Ari (University of Kentucky)
Role of CIC in Oncogenic MAPK Driven Expression of the PEA3 Family in Low Grade Serous Ovarian Cancer (#029)
Speaker: Andrew Polio (University of Iowa Hospitals and Clinics)
Impact of Video-Based Coaching on Surgical Proficiency and Comfort Level for Robot-Assisted Sentinel Lymph Node Dissection (SLND) Among Gynecologic Oncology Fellows (#030)
Speaker: Alysia Wiener (Karmanos Cancer Institute at Detroit Medical Center, Wayne State University)
Evaluating Gaps in Biobanking Consent and Specimen Collection in Gynecologic Cancer Research (#031)
Speaker: Hiruni Sumanasiri (The University of Iowa)